Bio News

China’s Zhongkangkexi announced that the country’s weight-loss product market across all channels reached 2.76 billion yuan in the first quarter of 2026. The figure was more than half the size of the full-year 2025 market and represented 304% growth from the same period a year earlier. Zhongkangkexi analyzed that sales of GLP-1 weight-loss drugs are shifting from online channels to offline pharmacies as regulations tighten, including a ban on the online sale of injectable drugs.

BIOBOOK TEAM
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882